Sage Therapeutics Inc (SAGE) — Capital Reinvestment Ratio
Sage Therapeutics Inc (SAGE) has a Capital Reinvestment Ratio of 0.00x as of December 2020, meaning it reinvests 0% of its operating cash flow ($1.01 Billion) in capital expenditures ($1.00K). Check Sage Therapeutics Inc tangible equity quality to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Sage Therapeutics Inc Capital Reinvestment Ratio (2020–2020)
This chart tracks Sage Therapeutics Inc's Capital Reinvestment Ratio across 1 annual periods. For the full cash flow conversion analysis, see cash flow conversion of Sage Therapeutics Inc.
Annual Capital Reinvestment Ratio for Sage Therapeutics Inc (2020–2020)
Year-by-year Capital Reinvestment Ratio for Sage Therapeutics Inc from 2020 to 2020. See Sage Therapeutics Inc (SAGE) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2020 | 0.00x | $664.28 Million | $345.00K | — |